Top Stocks in Bank of America Corp.’s $11.7B Healthcare Portfolio

Wall St. Watchdog reveals information regarding Bank of America Corp.’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 587 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $11.778 billion.

  • Abbott Laboratories (NYSE:ABT): On 06/30/2011, Bank of America Corp. reported holding 16,088,465 shares with a market value of $846,575,011. This comprised 0.57% of the total portfolio. On 09/30/2011, Bank of America Corp. reported holding 32,980,812 shares with a market value of $1,686,638,706. This comprised 1.06% of the total portfolio. The net change in shares for this position over the two quarters is 16,892,347. About Company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
  • Johnson & Johnson (NYSE:JNJ): On 06/30/2011, Bank of America Corp. reported holding 21,129,061 shares with a market value of $1,405,505,067. This comprised 0.94% of the total portfolio. On 09/30/2011, Bank of America Corp. reported holding 22,062,817 shares with a market value of $1,405,180,784. This comprised 0.88% of the total portfolio. The net change in shares for this position over the two quarters is 933,756. About Company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Pfizer Inc. (NYSE:PFE): On 06/30/2011, Bank of America Corp. reported holding 44,370,475 shares with a market value of $914,031,802. This comprised 0.61% of the total portfolio. On 09/30/2011, Bank of America Corp. reported holding 48,645,514 shares with a market value of $860,052,702. This comprised 0.54% of the total portfolio. The net change in shares for this position over the two quarters is 4,275,039. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Bristol-myers Squibb Company (NYSE:BMY): On 06/30/2011, Bank of America Corp. reported holding 11,833,878 shares with a market value of $342,709,096. This comprised 0.23% of the total portfolio. On 09/30/2011, Bank of America Corp. reported holding 24,483,314 shares with a market value of $768,286,373. This comprised 0.48% of the total portfolio. The net change in shares for this position over the two quarters is 12,649,436. About Company: Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company’s products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders.
  • Merck & Co. Inc. (NYSE:MRK): On 06/30/2011, Bank of America Corp. reported holding 17,917,744 shares with a market value of $632,317,202. This comprised 0.42% of the total portfolio. On 09/30/2011, Bank of America Corp. reported holding 18,866,021 shares with a market value of $616,918,901. This comprised 0.39% of the total portfolio. The net change in shares for this position over the two quarters is 948,277. About Company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.
  • Baxter International Inc. (NYSE:BAX): On 06/30/2011, Bank of America Corp. reported holding 4,541,571 shares with a market value of $271,086,367. This comprised 0.18% of the total portfolio. On 09/30/2011, Bank of America Corp. reported holding 10,618,026 shares with a market value of $596,095,973. This comprised 0.37% of the total portfolio. The net change in shares for this position over the two quarters is 6,076,455. About Company: Baxter International Inc. develops, manufactures, and markets products and technologies related to hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. The Company’s products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, and research laboratories.
  • Amgen Inc. (NASDAQ:AMGN): On 06/30/2011, Bank of America Corp. reported holding 5,547,621 shares with a market value of $323,703,677. This comprised 0.22% of the total portfolio. On 09/30/2011, Bank of America Corp. reported holding 10,677,846 shares with a market value of $586,854,406. This comprised 0.37% of the total portfolio. The net change in shares for this position over the two quarters is 5,130,225. About Company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.
  • Celgene Corporation (NASDAQ:CELG): On 06/30/2011, Bank of America Corp. reported holding 2,347,024 shares with a market value of $141,572,487. This comprised 0.1% of the total portfolio. On 09/30/2011, Bank of America Corp. reported holding 5,784,842 shares with a market value of $358,139,567. This comprised 0.22% of the total portfolio. The net change in shares for this position over the two quarters is 3,437,818. About Company: Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
  • Allergan Inc. (NYSE:AGN): On 06/30/2011, Bank of America Corp. reported holding 2,028,980 shares with a market value of $168,912,585. This comprised 0.11% of the total portfolio. On 09/30/2011, Bank of America Corp. reported holding 4,271,436 shares with a market value of $351,880,886. This comprised 0.22% of the total portfolio. The net change in shares for this position over the two quarters is 2,242,456. About Company: Allergan, Inc. is a multi-specialty health care company that discovers, develops and commercializes pharmaceuticals, biologics and medical devices. The Company develops products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets in countries around the world.
  • Gilead Sciences Inc. (NASDAQ:GILD): On 06/30/2011, Bank of America Corp. reported holding 8,281,146 shares with a market value of $342,922,255. This comprised 0.23% of the total portfolio. On 09/30/2011, Bank of America Corp. reported holding 8,694,253 shares with a market value of $337,337,010. This comprised 0.21% of the total portfolio. The net change in shares for this position over the two quarters is 413,107. About Company: Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company’s primary arees of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.

(Note: Data regarding Bank of America Corp.’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>